Table of Contents Author Guidelines Submit a Manuscript
Obstetrics and Gynecology International
Volume 2014, Article ID 945621, 5 pages
http://dx.doi.org/10.1155/2014/945621
Research Article

Maternal Characteristics of Women Exposed to Hypnotic Benzodiazepine Receptor Agonist during Pregnancy

1Department of Clinical Pharmacology, Bispebjerg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark
2Laboratory of Clinical Pharmacology Q7642, Rigshospitalet, 2100 Copenhagen, Denmark

Received 8 January 2014; Accepted 25 March 2014; Published 10 April 2014

Academic Editor: Deborah A. Wing

Copyright © 2014 Bjarke Askaa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Tamanna and S. A. Geraci, “Major sleep disorders among women: (Women’s Health Series),” Southern Medical Journal, vol. 106, no. 8, pp. 470–478, 2013. View at Google Scholar
  2. B. L. Hutchison, P. R. Stone, L. M. E. McCowan, A. W. Stewart, J. M. D. Thompson, and E. Mitchell, “A postal survey of maternal sleep in late pregnancy,” BMC Pregnancy Childbirth, vol. 12, no. 1, p. 144, 2012. View at Google Scholar
  3. T. Roehrs and T. Roth, “Hypnotics: an update,” Current Neurology and Neuroscience Reports, vol. 3, no. 2, pp. 181–184, 2003. View at Google Scholar · View at Scopus
  4. M. Lader, “Zopiclone: is there any dependence and abuse potential?” Journal of Neurology, Supplement, vol. 244, no. 1, pp. S18–S22, 1997. View at Google Scholar · View at Scopus
  5. A. Dang, A. Garg, and P. V. Rataboli, “Role of Zolpidem in the Management of Insomnia,” CNS Neuroscience and Therapeutics, vol. 17, no. 5, pp. 387–397, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Giorgi, D. A. Portela, G. Breghi, and A. Briganti, “Pharmacokinetics and pharmacodynamics of zolpidem after oral administration of a single dose in dogs,” American Journal of Veterinary Research, vol. 73, no. 10, pp. 1650–1656, 2012. View at Google Scholar
  7. S. Juric, D. J. Newport, J. C. Ritchie, M. Galanti, and Z. N. Stowe, “Zolpidem (Ambien) in pregnancy: placental passage and outcome,” Archives of Women's Mental Health, vol. 12, no. 6, pp. 441–446, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. L.-H. Wang, H.-C. Lin, C.-C. Lin, Y.-H. Chen, and H.-C. Lin, “Increased risk of adverse pregnancy outcomes in women receiving zolpidem during pregnancy,” Clinical Pharmacology and Therapeutics, vol. 88, no. 3, pp. 369–374, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. B. N. Wikner, C.-O. Stiller, U. Bergman, C. Asker, and B. Källén, “Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations,” Pharmacoepidemiology and Drug Safety, vol. 16, no. 11, pp. 1203–1210, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. B. N. Wikner and B. Källén, “Are hypnotic benzodiazepine receptor agonists teratogenic in humans?” Journal of Clinical Psychopharmacology, vol. 31, no. 3, pp. 356–359, 2011. View at Google Scholar
  11. B. Källén, N. Borg, and M. Reis, “The use of central nervous system active drugs during pregnancy,” Pharmaceuticals, vol. 6, no. 10, pp. 1221–1286, 2013. View at Google Scholar
  12. O. Diav-Citrin, B. Okotore, K. Lucarelli, and G. Koren, “Zopiclone use during pregnancy,” Canadian Family Physician, vol. 46, pp. 63–64, 2000. View at Google Scholar · View at Scopus
  13. L. B. Knudsen and J. Olsen, “The Danish medical birth registry,” Danish Medical Bulletin, vol. 45, no. 3, pp. 320–323, 1998. View at Google Scholar · View at Scopus
  14. J. Kristensen, J. Langhoff-Roos, L. Theil Skovgaard, and F. Børlum Kristensen, “Validation of the Danish birth registration,” Journal of Clinical Epidemiology, vol. 49, no. 8, pp. 893–897, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Gaist, H. T. Sørensen, and J. Hallas, “The Danish prescription registries,” Danish Medical Bulletin, vol. 44, no. 4, pp. 445–448, 1997. View at Google Scholar
  16. H. Wallach Kildemoes, H. Toft Sørensen, and J. Hallas, “The Danish national prescription registry,” Scandinavian Journal of Public Health, vol. 39, no. 7, pp. 38–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. H. T. Sørensen, I. Hansen, E. Ejlersen, S. Sabroe, and H. Hamburger, “Identification of patients treated with strong analgesics: an assessment of two Danish information systems with respect to epidemiological research,” Journal of Medical Systems, vol. 20, no. 1, pp. 57–65, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Baadsgaard and J. Quitzau, “Danish registers on personal income and transfer payments,” Scandinavian Journal of Public Health, vol. 39, no. 7, pp. 103–105, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. V. M. Jensen and A. W. Rasmussen, “Danish education registers,” Scandinavian Journal of Public Health, vol. 39, no. 7, pp. 91–94, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Little, J. P. T. Higgins, J. P. A. Ioannidis et al., “STrengthening the REporting of genetic association studies (STREGA)-an extension of the strobe statement,” PLoS Medicine, vol. 6, no. 2, article e22, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. B. N. Wikner, C.-O. Stiller, B. Källén, and C. Asker, “Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: maternal characteristics,” Pharmacoepidemiology and Drug Safety, vol. 16, no. 9, pp. 988–994, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. B. S. Toft, “Status på benzodiazepinindsatsen,” Danish, 2010, http://irf.dk/dk/publikationer/rationel_farmakoterapi/maanedsblad/2010/maanedsblad_nr_3_marts_2010.htm.
  23. S. Alwan, J. Reefhuis, S. A. Rasmussen, and J. M. Friedman, “Patterns of antidepressant medication use among pregnant women in a united states population,” Journal of Clinical Pharmacology, vol. 51, no. 2, pp. 264–270, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Jimenez-Solem, J. T. Andersen, M. Petersen et al., “Prevalence of antidepressant use during pregnancy in Denmark, A Nation-Wide Cohort Study,” PLoS One, vol. 8, no. 4, article e63034, 2013. View at Google Scholar
  25. G. M. Asnis, A. Chakraburtty, E. A. DuBoff et al., “Zolpidem for persistent insomnia in SSRI-treated depressed patients,” Journal of Clinical Psychiatry, vol. 60, no. 10, pp. 668–676, 1999. View at Google Scholar · View at Scopus
  26. M. E. Thase, “Depression and sleep: pathophysiology and treatment,” Dialogues in Clinical Neuroscience, vol. 8, no. 2, pp. 217–226, 2006. View at Google Scholar · View at Scopus
  27. L. T. De Jong van den Berg, N. Feenstra, H. T. Sorensen, and M. C. Cornel, “Improvement of drug exposure data in a registration of congenital anomalies. Pilot-Study: pharmacist and mother as sources for drug exposure data during pregnancy. EuroMAP Group. Europen Medicine and Pregnancy Group,” Teratology, vol. 60, no. 1, pp. 33–36, 1999. View at Google Scholar